cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Fate Therapeutics Inc
13 own
13 watching
Current Price
$6.37
$0.41
(6.88%)
logo-fate
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
618.6M
52-Week High
52-Week High
43.12
52-Week Low
52-Week Low
4.02
Average Volume
Average Volume
2.43M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization618.6M
icon52-Week High43.12
icon52-Week Low4.02
iconAverage Volume2.43M
iconDividend Yield--
iconP/E Ratio--
What does the Fate Therapeutics Inc do?
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its immuno-oncology product candidates include FATE-NK100, a natural killer (NK) cell cancer immunotherapy that consists of adaptive memory NK cells; engineered hnCD16 induced pluripotent stem cells (iPSC)-derived natural killer cell therapy candidates for hematologic/solid tumors; and engineered chimeric antigen receptor iPSC-derived T cell therapy product candidates for hematologic/solid tumors. The company's immuno-regulation product candidates comprise ProTmune, an investigational programmed cellular immunotherapy for use as a next-generation allogeneic hematopoietic cell transplantation cell graft; and ToleraCyte for the treatment of autoimmune and inflammatory diseases; engineered iPSC-derived CD34+ cell therapy for immune disorders. Fate Therapeutics, Inc. has a research collaboration and license agreement with Memorial Sloan Kettering Cancer Center to develop off-the-shelf T-cell immunotherapies; and strategic research collaboration and license agreement with Juno Therapeutics, Inc. to identify small molecule modulators that enhance the function of T cells. Fate Therapeutics, Inc. was founded in 2007 and is headquartered in San Diego, California.
Read More
How much money does Fate Therapeutics Inc make?
News & Events about Fate Therapeutics Inc.
Business Wire
1hours ago
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired Fate Therapeutics, Inc. (Fate) (NASDAQ: FATE) securities during the period from April 2, 2020 through January...
PR Newswire
1day ago
Bronstein, Gewirtz & Grossman, LLC Notifies Fate Therapeutics, Inc. (FATE) Investors of Class Action and to Actively Participate Bronstein, Gewirtz & Grossman, LLC Notifies Fate Therapeutics, Inc. (FATE) Investors of Class Action and to Actively Participate PR Newswire NEW YORK...
Globe Newswire
1day ago
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fate Therapeutics, Inc. (NASDAQ: FATE) securities between April 2, 2020 and January 5, 2023, inclusive (the Class Period) have until March 22, 2023 to seek ...
Globe Newswire
3days ago
NEW YORK, Jan. 29, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Fate Therapeutics, Inc. (NASDAQ: FATE), and Sotera Health Co. (NASDAQ: SHC). ...
PR Newswire
5days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class...
Frequently Asked Questions
Frequently Asked Questions
What is Fate Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Fate Therapeutics Inc shares?
plus_minus_icon
How can I buy Fate Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Fate Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Fate Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Fate Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Fate Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Fate Therapeutics Inc?
plus_minus_icon
What percentage is Fate Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Fate Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$6.37
$0.41
(6.88%)
logo-fate
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00